Electromedical Technologies Inc
OTC:EMED
Balance Sheet
Balance Sheet Decomposition
Electromedical Technologies Inc
Electromedical Technologies Inc
Balance Sheet
Electromedical Technologies Inc
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-24%
|
1
-10%
|
1
-17%
|
1
-8%
|
1
+57%
|
1
-1%
|
1
-3%
|
1
-45%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Total Current Liabilities |
1
|
1
|
1
|
2
|
2
|
2
|
1
|
3
|
3
|
|
| Long-Term Debt |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
2
-11%
|
2
+25%
|
3
+49%
|
3
+2%
|
3
-11%
|
2
-22%
|
4
+68%
|
4
+1%
|
|
| Equity | ||||||||||
| Common Stock |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Retained Earnings |
1
|
1
|
2
|
4
|
5
|
10
|
22
|
25
|
27
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
1
|
3
|
8
|
21
|
22
|
24
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-188%
|
1
-164%
|
2
-140%
|
2
-6%
|
1
+40%
|
1
+45%
|
2
-207%
|
3
-29%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-24%
|
1
-10%
|
1
-17%
|
1
-8%
|
1
+57%
|
1
-1%
|
1
-3%
|
1
-45%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
31
|
31
|
27
|
88
|
190
|
463
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|